189 related articles for article (PubMed ID: 2417929)
1. Phenotypic characterization of 'non-T, non-B' acute lymphoblastic leukemia by a new panel (BL) of monoclonal antibodies.
Al-Katib A; Wang CY; Bardales R; Koziner B
Hematol Oncol; 1985; 3(4):271-81. PubMed ID: 2417929
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes.
Wang CY; Azzo W; Al-Katib A; Chiorazzi N; Knowles DM
J Immunol; 1984 Aug; 133(2):684-91. PubMed ID: 6429242
[TBL] [Abstract][Full Text] [Related]
3. B-lymphocyte associated differentiation antigen expression by 'non-B, non-T' acute lymphoblastic leukemia.
Flug F; Dodson L; Wolff J; Guarini L; Rausen A; Wang CY; Knowles DM
Leuk Res; 1985; 9(8):1051-8. PubMed ID: 2931557
[TBL] [Abstract][Full Text] [Related]
4. Quantitative variation of the common acute lymphoblastic leukemia antigen (gp100) on leukemic marrow blasts.
Look AT; Melvin SL; Brown LK; Dockter ME; Roberson PK; Murphy SB
J Clin Invest; 1984 Jun; 73(6):1617-28. PubMed ID: 6233301
[TBL] [Abstract][Full Text] [Related]
5. Detection of the common acute lymphoblastic leukaemia antigen (CALLA) on B cells from human fetal tissues. A multiple phenotypic characterization.
Delia D; Cattoretti G; Bonati A; Villa S; De Braud F; Buscaglia M
Clin Exp Immunol; 1985 Feb; 59(2):305-14. PubMed ID: 2579752
[TBL] [Abstract][Full Text] [Related]
6. Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes.
van Dongen JJ; Hooijkaas H; Comans-Bitter M; Hählen K; de Klein A; van Zanen GE; van't Veer MB; Abels J; Benner R
J Immunol; 1985 Nov; 135(5):3144-50. PubMed ID: 2413114
[TBL] [Abstract][Full Text] [Related]
7. Cell surface markers in leukemia: biological and clinical correlations.
Thiel E
Crit Rev Oncol Hematol; 1985; 2(3):209-60. PubMed ID: 3013441
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of monoclonal antibodies recognizing two distinct differentiation antigens (Pro-Im1, Pro-Im2) on early hematopoietic cells.
Peng R; Al-Katib A; Knowles DM; Lu L; Broxmeyer H; Tolidjian B; Chiao JW; Koziner B; Wang CY
Blood; 1984 Dec; 64(6):1169-78. PubMed ID: 6388662
[TBL] [Abstract][Full Text] [Related]
9. [Surface membrane receptors, differentiation antigens and cytochemical characteristics of blood cells in acute lymphoblastic leukemia in children].
Gluzman DF; Skliarenko LM; Nadgornaia VA; Poludnenko LIu; Sidorenko SP
Eksp Onkol; 1987; 9(3):36-9. PubMed ID: 2956083
[TBL] [Abstract][Full Text] [Related]
10. Acute lymphoblastic leukemia (ALL) antigens detected with antisera to E rosette-froming and non-E rosette-forming ALL blasts.
Borella L; Sen L; Casper JT
J Immunol; 1977 Jan; 118(1):309-15. PubMed ID: 318669
[TBL] [Abstract][Full Text] [Related]
11. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies.
Zipf TF; Fox RI; Dilley J; Levy R
Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of non-T, non-B acute lymphocytic leukemia defined by the quantitative expression of Ia and common all antigens.
Okamura J; Letarte M; Gelfand EW
Leuk Res; 1984; 8(3):335-43. PubMed ID: 6235405
[TBL] [Abstract][Full Text] [Related]
13. Ia+T10+ blast cells in acute lymphoblastic leukaemia are precursors of T+ and B+ cells.
Miljković AK; Isaković K; Matejić T; Stojanović B
Adv Exp Med Biol; 1985; 186():1017-25. PubMed ID: 3931426
[TBL] [Abstract][Full Text] [Related]
14. Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies.
Quackenbush EJ; Letarte M
J Immunol; 1985 Feb; 134(2):1276-85. PubMed ID: 3155538
[TBL] [Abstract][Full Text] [Related]
15. Immunological subclassification of non-T, non-B acute lymphoblastic leukaemia in childhood.
Komada Y; Azuma E; Tanaka S; Ochiai H; Sakurai M
Scand J Haematol; 1986 Jan; 36(1):85-91. PubMed ID: 2937137
[TBL] [Abstract][Full Text] [Related]
16. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
17. A new human B-lymphocyte surface antigen (BL 2) detectable by a hybridoma monoclonal antibody: distribution on benign and malignant lymphoid cells.
Knowles DM; Tolidjian B; Marboe CC; Halper JP; Azzo W; Wang CY
Blood; 1983 Jul; 62(1):191-9. PubMed ID: 6190520
[TBL] [Abstract][Full Text] [Related]
18. Acute mixed lineage leukemia: clinicopathologic correlations and prognostic significance.
Mirro J; Zipf TF; Pui CH; Kitchingman G; Williams D; Melvin S; Murphy SB; Stass S
Blood; 1985 Nov; 66(5):1115-23. PubMed ID: 3931724
[TBL] [Abstract][Full Text] [Related]
19. Two new acute lymphoblastic leukemia cell lines with early B-cell phenotypes.
Findley HW; Cooper MD; Kim TH; Alvarado C; Ragab AH
Blood; 1982 Dec; 60(6):1305-9. PubMed ID: 6982733
[TBL] [Abstract][Full Text] [Related]
20. Expression of the common acute lymphoblastic leukemia antigen (CALLA) on the surface of individual cells of human lymphoblastoid lines.
Goldmacher VS; Lambert JM; Young AY; Anderson J; Tinnel NL; Kornacki M; Ritz J; Blättler WA
J Immunol; 1986 Jan; 136(1):320-5. PubMed ID: 2415623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
